-+ 0.00%
-+ 0.00%
-+ 0.00%

FibroBiologics director Kathleen Hallisey Rubins files initial beneficial ownership statement

PUBT·07/16/2026 20:01:14
Listen to the news
FibroBiologics director Kathleen Hallisey Rubins files initial beneficial ownership statement
  • FibroBiologics director Kathleen Hallisey Rubins reported a stock option for 562 common shares at $65.6, expiring Sept. 26, 2032.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033509), on July 16, 2026, and is solely responsible for the information contained therein.